Form D · Other Health Care

ExceleraRx Corp.

Minneapolis, MN · CIK 0001530655

Offering snapshot reported Nov 21, 2019 · SEC filing

Reported sold
$2M
Offering amount: $6M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 8, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 21, 2019Initial$2,000,000No comparison5SEC filing
Jan 9, 2018Initial$2,575,000No comparison6SEC filing
Oct 3, 2011Initial$300,000No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-353946

Source: Form D, filed Nov 21, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Nick Barto Director
Robert Beacher Director
Mark Brodin Director, Promoter
George Chresand Executive
David Christensen Director, Promoter
Dave Fasching Executive, Promoter
James M. Fox Director, Executive
Craig Frost Director
Russell Funk Director
Karna Halverson Executive
Daniel Kus Director
Sandra Mayasich Executive
Pamela M. Nenaber Director
Stephen Petersen Director, Promoter
Scott Peterson Director
Gary S. Plank Director, Promoter
Troy Polan Director, Executive
John Polanski Director, Promoter
Albert Zimmerli Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
2100 Summer Street Ne Suite 260
Minneapolis, MN, 55413